are they banning compounded semaglutide Drugmakers battle pharmacies over Ozempic and Zepbound : Shots FDA moves to remove GLP-1

Boesen has been involved with amicus, or friend of the court, briefs in lawsuits brought by Novo Nordisk and Eli Lilly over GLP-1 compounding, and is currently representing a med spa in a GLP-1-related case brought by Eli Lilly earlier this month

Indeed, these studies were originally designed primarily as safety studies, and the accumulation of a large number of CV events in high-risk patients was a strategy to limit the sample size and duration of these trials [37]

Obesity is a chronic condition, just like diabetes

Regulatory authorities do not approve it for human or veterinary use

For a medication protocol that requires titration management and side effect oversight, that's a real differentiator from platforms that offer one intake consultation and ship medication without ongoing support

Understanding what to expect, and knowing that support is available, can make treatment feel far more manageable